Actuate Therapeutics ACTU
NASDAQ ACTU
$1.27 +0.04 (+3.25%)
At close: Aug 21, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Interest Coverage Ratio Growth (1y) (2024 - 2025)

Actuate Therapeutics (ACTU) Interest Coverage Ratio Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -60.78%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -25.59%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1,170.12%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 751.68%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 99.48%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -53.46%
10 Actuate Therapeutics 30.08 Mn 30.08 Mn - 17.81%

Historic Data

Download Data
DateValue
Dec 31, 2025 -167.05%
Sep 30, 2025 30.07%
Jun 30, 2025 -10.12%
Mar 31, 2025 17.90%
Dec 31, 2024 108.34%
Sep 30, 2024 -20.83%
Jun 30, 2024 2.94%